Impact of a 'trigger list' on reporting of adverse drug events

被引：0
|
作者：
Boon, G. R. [1 ]
Cavell, G. F. [1 ]
Morse, S. L. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Dept Pharm, London, England
来源：
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：467 / 468
页数：2
相关论文
共 50 条
  • [1] IMPACT OF EDUCATIONAL INTERVENTIONS ON ADVERSE DRUG EVENTS REPORTING
    Pagotto, Caroline
    Varallo, Fabiana
    Mastroianni, Patricia
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (04) : 410 - 417
  • [2] Reporting Adverse Drug Events
    Feagins, Linda A.
    Abdelsayed, George G.
    Schairer, Jason
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1411 - 1413
  • [3] FACTORS THAT IMPACT REPORTING OF ADVERSE DRUG EVENTS BY PHARMACISTS: A SYSTEMATIC LITERATURE REVIEW
    Arabyat, R. M.
    Raisch, D. W.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A23 - A23
  • [4] Specificity of trigger drugs as indicators of adverse drug events
    Boon, G.
    Morse, S.
    Cavell, G.
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (03): : 281 - 283
  • [5] Global Trigger Tool detects adverse drug events
    [J]. Reactions Weekly, 2023, 1949 (1) : 10 - 10
  • [6] Number of Biochemical Tests as a Trigger for Adverse Drug Events
    Zaal, Rianne J.
    Lindemans, Anouk D.
    Boedhram, Ryan R.
    Doormaal, Jasperien Evan
    Kosterink, Jos G. W.
    Haaijer-Ruskamp, Flora M.
    Vulto, Arnold G.
    van den Bemt, Patricia M. L. A.
    Mol, Peter G. M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 109 - 109
  • [7] Flumazenil as Trigger Tool for Measuring Adverse Drug Events
    Ng, Sock Ping
    Wu, Hsiu Ling
    Talbot, Alan Ronaldmp
    Chien, Su Yu
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 420 - 420
  • [8] NUMBER OF BIOCHEMICAL TESTS AS A TRIGGER FOR ADVERSE DRUG EVENTS
    Zaal, R. J.
    Lindemans, A. D.
    Boedhram, R. R.
    van Doormaal, J. E.
    Kosterink, J. G. W.
    Haaijer-Ruskamp, F. M.
    Vulto, A. G.
    van den Bemt, P. M. L. A.
    Mol, P. G. M.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) : 775 - 775
  • [9] Specificity of trigger drugs as indicators of adverse drug events
    Boon, G.
    Morse, S.
    Cavell, G.
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (04): : 416 - 417
  • [10] REPORTING OF ADVERSE DRUG EVENTS - A KEY TO POSTMARKETING DRUG SAFETY
    RHEINSTEIN, PH
    [J]. AMERICAN FAMILY PHYSICIAN, 1992, 46 (03) : 873 - 874
12345